Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.46 |
| ▸ | PRKCA | P17252 | 12/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL14723526 | 0.87 | SIRT2 (0.36) | SIRT2PRKCA | |
| SCHEMBL14731586 | 0.85 | SIRT2 (0.33) | SIRT2PRKCA | |
| SCHEMBL3659630 | 0.73 | SIRT2 (0.50) | SIRT2PRKCACYP1A2CYP19A1 | |
| SCHEMBL10186571 | 0.71 | SIRT2 (0.53) | SIRT2PRKCACYP1A2 | |
| SCHEMBL15526485 | 0.71 | SIRT2 (0.53) | SIRT2PRKCACYP1A2 | |
| SCHEMBL663852 | 0.71 | SIRT2 (0.53) | SIRT2PRKCACYP1A2 | |
| SCHEMBL16016876 | 0.71 | SIRT2 (0.53) | SIRT2PRKCA | |
| SCHEMBL112728 | 0.71 | SIRT2 (0.53) | SIRT2PRKCACYP1A2 | |
| SCHEMBL10186569 | 0.71 | SIRT2 (0.53) | SIRT2PRKCACYP1A2 | |
| SCHEMBL3659625 | 0.71 | SIRT2 (0.53) | SIRT2PRKCACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9920084-B2 | Ionic tags for synthesis of oligoribonucleotides | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2018-03-20 | — | — | US | disclosed |
| US-20140256926-A1 | Ionic Tags for Synthesis of Oligoribonucleotides | HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2014-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256926-A1 | Ionic Tags for Synthesis of Oligoribonucleotides | RNGTT, OSTC, OSGEP | SIRT2 2931/4885PRKCA 4039/4885CYP1A2 4665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.